The optimal cutoff values of CK18 were calculated among 76 NASH patients to maximize sensitivity and specificity for the prediction of the presence of early fibrosis development (F1), significant fibrosis (F2), and advanced fibrosis (F3-4), respectively (Table 2). Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.